Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer-Reference-Cited by-同舟云学术

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

Published:1989-12 Issue:3 Volume:14 Page:289-298
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Manni Andrea,Boucher Alice E.,Demers Laurence M.,Harvey Harold A.,Lipton Allan,Simmonds Mary A.,Bartholomew Mary

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01806300.pdf

Reference30 articles.

1. Manni A, Pearson OH: Antioestrogens in tumor therapy. Clin Oncol 1: 65–75, 1982

2. Lippman M, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601, 1976

3. Nagasawa H: Prolactin and human breast cancer: a review. Eur J Cancer 15: 267–279, 1979

4. Pearson OH, Manni A, Chambers M, Brodkey J, Marshall JS: The role of pituitary hormones in the growth of human breast cancer. Cancer Res 38: 4323–4326, 1978

5. Holdaway IA, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res 37: 1946–1951, 1977

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on the Multimodal Role of Biomarkers in Breast Cancer;Current Pharmaceutical Design;2021-10-22

2. Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients;Annals of Diagnostic Pathology;2020-06

3. A review of the use of somatostatin analogs in oncology;OncoTargets and Therapy;2013-04

4. Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association;Gynecological Endocrinology;2012-03-16

5. Somatostatin in breast cancer;Annales de biologie clinique;2011-07